Skip to content

Soft-tissue-Sarcoma

A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities (Soft-tissue-Sarcoma)

Pre-treatment FDG PET/CT and T1-weighted plus fat-suppressed T2-weighted or STIR MRI of 51 patients with soft-tissue sarcoma of the extremities from McGill, with tumor contours, clinical data and lung metastasis outcome labels.

Overview

Soft-tissue-Sarcoma is a radiomics collection from McGill University, published by The Cancer Imaging Archive in 2015 together with the study by Vallières and colleagues in Physics in Medicine and Biology. It pairs pre-treatment FDG PET/CT and MRI of patients with soft-tissue sarcoma of the arms and legs with manual tumor contours and follow-up data, and was assembled to test whether texture features from fused PET and MRI predict which patients later develop lung metastases.

Composition

The Data Access table lists 51 subjects, 102 studies, 612 DICOM series and 38,283 images (9.87 GB). Every patient has one PET/CT study and one MR study. The cohort was imaged between November 2004 and November 2011, before treatment, and patients who already had metastatic or recurrent disease at presentation were excluded. Nineteen patients developed lung metastases during follow-up. In the open clinical spreadsheet, the thigh is the most frequent primary site (28 patients), the most frequent histology groups are malignant fibrous histiocytoma (17), liposarcoma (11) and leiomyosarcoma (10), and 28 tumors are high grade. It also records treatment, outcome and follow-up times.

Acquisition

All PET/CT scans come from one GE Discovery ST at the McGill University Health Centre, acquired about an hour after FDG injection. MRI was clinical routine with protocols that varied between patients: 12 exams were done at the same centre and 39 elsewhere, on GE, Philips and Siemens scanners. Each patient has an axial T1-weighted series and one fat-suppressed fluid-sensitive series, either T2-weighted fat saturated (26 patients) or STIR (25 patients). Copies of both MR series registered and resampled to the PET grid are included.

Annotations

A radiation oncologist drew 3D tumor contours slice by slice on the fat-suppressed MR series. For the 32 patients with visible edema there are two contours, one for the mass alone and one that includes the edema. The contours were transferred to the PET, CT and T1-weighted series by rigid registration and are stored as RTSTRUCT objects for every series. The binary lung metastasis label is given per patient.

Known limitations

  • Small single-centre cohort with 19 positive cases for the main outcome.
  • MRI protocols, planes and scanners are not uniform, and the T2-weighted and STIR series are pooled as one category.
  • Dates in the images were shifted for de-identification.
  • Contours on PET, CT and T1-weighted images are propagated by registration, not drawn on those images.

Cohort

Aggregate numbers from the sources below. Bars are relative to the 51 subjects.

Sex

  • Female 27 53%
  • Male 24 47%

Age

mean 54.8± 17 · range 16 to 83
0
5
10
15
15
10-1920-2930-3940-4950-5960-6970-7980-89

Contrast combinations

How many subjects have exactly each set of contrasts.

T1wT2wSTIRSubjects with exactly this set
26
25

Modality

subjects

  • CT 51 100%
  • PET 51 100%
  • MRI 51 100%

Contrast / sequence

subjects, values can overlap

  • T1-weighted 51 100%
  • T2-weighted 26 51%
  • STIR 25 49%

PET tracer

subjects

  • [18F]FDG 51 100%

Condition

subjects, values can overlap

  • Soft tissue sarcoma 51 100%

Scanner vendor

subjects

  • GE HealthCare 51 100%
  • Philips 9 18%
  • Siemens Healthineers 8 16%

Country

subjects

  • Canada 51 100%

License and access

Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer

Access
Open download

Download without an account

DICOM images and RTSTRUCT contours are downloaded with the TCIA Data Retriever from a manifest file and are also available in the NCI Imaging Data Commons. The clinical spreadsheet is a direct download. No account is needed.

Access page

Creative Commons Attribution 3.0 Unported

Older version of CC BY. Use, share and adapt the data for any purpose, including commercial use, as long as you credit the creators.

The Data Access table lists CC BY 3.0 for both the images with radiation therapy structures and the clinical data. The page also requires the data citation under the TCIA Data Usage Policy.

Original license text Version read: 3.0 Checked 2026-10-07

What you can do

  • Yes
  • Yes
  • Yes
  • Yes

What you can share

  • Yes
  • Yes
  • Yes

What you must do

  • Yes
  • Share alike No
  • No
  • No
  • Manuscript review No
  • Release code No
  • Return results No
  • Delete after use No

Limits

  • No
  • Location limits No

Citation

Vallières, M., Freeman, C. R., Skamene, S. R., & El Naqa, I. (2015). A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities (Soft-tissue-Sarcoma) [Dataset]. The Cancer Imaging Archive. https://doi.org/10.7937/K9/TCIA.2015.7GO2GSKS

All numbers

Every number on this page, as stored in stats.csv, with its source.

MeasureBreakdownValueSource
Subjectstotal 51tcia-soft-tissue-sarcoma
Data Access (Version 1)
Studiestotal
one PET/CT study and one MR study per patient
102tcia-soft-tissue-sarcoma
Data Access (Version 1)
Scanstotal
DICOM series, including RTSTRUCT and the MR series registered to PET
612tcia-soft-tissue-sarcoma
Data Access (Version 1)
Imagestotal
DICOM images
38,283tcia-soft-tissue-sarcoma
Data Access (Version 1)
Subjectscondition=soft_tissue_sarcoma
histologically proven STS of the extremities
51vallieres2015
Abstract
Subjectsmodality=CT
CT of the PET/CT exam
51tcia-sts-digest
Patient ID, Modality columns
Subjectsmodality=PT 51tcia-sts-digest
Patient ID, Modality columns
Subjectsmodality=MR 51tcia-sts-digest
Patient ID, Modality columns
Subjectstracer=fdg 51tcia-soft-tissue-sarcoma
Detailed Description
Scansmodality=CT 51tcia-sts-digest
Series Instance UID, Modality columns
Scansmodality=PT 51tcia-sts-digest
Series Instance UID, Modality columns
Scansmodality=MR
102 clinical MR series plus 102 copies registered and resampled to PET
204tcia-sts-digest
Series Instance UID, Modality columns
Subjectscontrast=T1w
axial T1-weighted for all patients
51tcia-soft-tissue-sarcoma
Detailed Description
Subjectscontrast=T2w
T2-weighted fat-saturated
26tcia-soft-tissue-sarcoma
Detailed Description
Subjectscontrast=STIR
used where no T2-weighted fat-saturated series was available
25tcia-soft-tissue-sarcoma
Detailed Description
Subjectscontrast_set=T1w+T2w
registered series Aligned_T1toPET and Aligned_T2FStoPET
26tcia-sts-digest
Patient ID, Series Description columns
Subjectscontrast_set=STIR+T1w
registered series Aligned_T1toPET and Aligned_STIRtoPET
25tcia-sts-digest
Patient ID, Series Description columns
Subjectsvendor=ge
GE Discovery ST PET/CT for all; 33 subjects also have GE MRI
51tcia-sts-digest
Patient ID, Manufacturer columns
Subjectsvendor=philips
MRI
9tcia-sts-digest
Patient ID, Manufacturer columns
Subjectsvendor=siemens
MRI
8tcia-sts-digest
Patient ID, Manufacturer columns
Subjectscountry=CA
all PET/CT scans at the McGill University Health Centre, Montreal; 39 MRI exams came from an outside institution
51tcia-soft-tissue-sarcoma
Detailed Description, Acknowledgements
Subjectssex=female 27tcia-sts-clinical
Patient ID, Sex columns
Subjectssex=male 24tcia-sts-clinical
Patient ID, Sex columns
Subjectsage=10-19 2tcia-sts-clinical
Patient ID, Age columns
Subjectsage=20-29 5tcia-sts-clinical
Patient ID, Age columns
Subjectsage=30-39 2tcia-sts-clinical
Patient ID, Age columns
Subjectsage=40-49 8tcia-sts-clinical
Patient ID, Age columns
Subjectsage=50-59 9tcia-sts-clinical
Patient ID, Age columns
Subjectsage=60-69 15tcia-sts-clinical
Patient ID, Age columns
Subjectsage=70-79 8tcia-sts-clinical
Patient ID, Age columns
Subjectsage=80-89 2tcia-sts-clinical
Patient ID, Age columns
Mean agetotal 54.8tcia-sts-clinical
Age column
Age SDtotal 17tcia-sts-clinical
Age column
Median agetotal 59tcia-sts-clinical
Age column
Minimum agetotal 16tcia-sts-clinical
Age column
Maximum agetotal 83tcia-sts-clinical
Age column

Sources

The keys used in the table above.